Investment Management Corp VA ADV Makes New Investment in VanEck Pharmaceutical ETF (NASDAQ:PPH)

Investment Management Corp VA ADV bought a new position in VanEck Pharmaceutical ETF (NASDAQ:PPH) in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The firm bought 5,307 shares of the company’s stock, valued at approximately $458,000. Investment Management Corp VA ADV owned about 0.09% of VanEck Pharmaceutical ETF at the end of the most recent quarter.

Several other institutional investors have also recently made changes to their positions in PPH. Mivtachim The Workers Social Insurance Fund Ltd. Under Special Management lifted its holdings in shares of VanEck Pharmaceutical ETF by 117.4% in the 4th quarter. Mivtachim The Workers Social Insurance Fund Ltd. Under Special Management now owns 200,000 shares of the company’s stock worth $17,256,000 after acquiring an additional 108,000 shares during the last quarter. Grimes & Company Inc. bought a new stake in shares of VanEck Pharmaceutical ETF in the 4th quarter worth about $310,000. Adamsbrown Wealth Consultants LLC lifted its holdings in shares of VanEck Pharmaceutical ETF by 102.3% in the 4th quarter. Adamsbrown Wealth Consultants LLC now owns 149,631 shares of the company’s stock worth $12,910,000 after acquiring an additional 75,659 shares during the last quarter. Stratos Wealth Advisors LLC lifted its holdings in shares of VanEck Pharmaceutical ETF by 8.7% in the 4th quarter. Stratos Wealth Advisors LLC now owns 14,192 shares of the company’s stock worth $1,224,000 after acquiring an additional 1,133 shares during the last quarter. Finally, Elm3 Financial Group LLC bought a new stake in shares of VanEck Pharmaceutical ETF in the 4th quarter worth about $324,000.

VanEck Pharmaceutical ETF Trading Down 0.0%

VanEck Pharmaceutical ETF stock opened at $86.18 on Friday. The firm has a 50-day moving average price of $86.59 and a 200-day moving average price of $88.24. The firm has a market capitalization of $619.63 million, a PE ratio of 24.60 and a beta of 0.72. VanEck Pharmaceutical ETF has a 12-month low of $77.67 and a 12-month high of $99.51.

VanEck Pharmaceutical ETF Increases Dividend

The company also recently announced a quarterly dividend, which was paid on Friday, April 4th. Stockholders of record on Tuesday, April 1st were issued a $0.5245 dividend. This represents a $2.10 annualized dividend and a dividend yield of 2.43%. The ex-dividend date of this dividend was Tuesday, April 1st. This is a positive change from VanEck Pharmaceutical ETF’s previous quarterly dividend of $0.31.

VanEck Pharmaceutical ETF Profile

The VanEck Pharmaceutical ETF (PPH) is an exchange-traded fund that is based on the MVIS US Listed Pharmaceutical 25 index, a market-cap-weighted index of 25 of the largest global pharmaceutical firms. PPH was launched on Feb 1, 2000 and is managed by VanEck.